Inside STAT: A health care veteran tries to upend the system and bring drug prices down

ALEXIS BORISY, 47, CO-FOUNDED FOUNDATION MEDICINE AND BLUEPRINT MEDICINES. (HYACINTH EMPINADO/STAT)

New government policies or nonprofits are the usual sources of proposals to help bring drug prices down, but in an unlikely move, a Boston-based venture capitalist is launching a new company today to do just that. Alex Borisy, the co-founder of such genetics-focused companies as Foundation Medicine and Blueprint Medicines, is now CEO and chairman of EQRx, whose mission will be to create new medicines that mimic the effects of blockbuster drugs, but to sell these versions to insurers and hospital systems at lower prices. This “radical proposition,” as Borisy calls his new idea, “is not [a] fantasy world,” he tells STAT’s Matthew Herper. “This is something that can be done.” Read more here.